In fact, during the 3-year follow-up, 27% of the LN patients exhibited a decrease in eGFR and an upstaging in the KDIGO classification of CKD, and this LN subpopulation exhibiting disease progression also presented with increased DKK3 serum levels at baseline. This evidence concerns the gene DKK3 and chronic kidney disease.